Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
Nom du journal : Lancet Oncol
Année : 2008
Volume : 9
Page de départ : 23
Page de fin : 28